This mergers and acquisitions consulting service helps pharmaceutical companies make strategy-led business development and licensing decisions. It supports the full deal lifecycle — from identifying acquisition targets and screening partners to conducting commercial due diligence, shaping negotiation strategy and managing post-deal integration.